Cargando…
mRNA trans‐splicing in gene therapy for genetic diseases
Spliceosome‐mediated RNA trans‐splicing, or SMaRT, is a promising strategy to design innovative gene therapy solutions for currently intractable genetic diseases. SMaRT relies on the correction of mutations at the post‐transcriptional level by modifying the mRNA sequence. To achieve this, an exogeno...
Autores principales: | Berger, Adeline, Maire, Séverine, Gaillard, Marie‐Claude, Sahel, José‐Alain, Hantraye, Philippe, Bemelmans, Alexis‐Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071737/ https://www.ncbi.nlm.nih.gov/pubmed/27018401 http://dx.doi.org/10.1002/wrna.1347 |
Ejemplares similares
-
Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans-Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa
por: Berger, Adeline, et al.
Publicado: (2015) -
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA
por: Dooley, Scott J., et al.
Publicado: (2018) -
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing
por: Trochet, Delphine, et al.
Publicado: (2016) -
A trans-spliced leader sequence on actin mRNA in C. elegans
por: Krause, Michael, et al.
Publicado: (1987) -
Spectral-Domain Optical Coherence Tomography of the Rodent Eye: Highlighting Layers of the Outer Retina Using Signal Averaging and Comparison with Histology
por: Berger, Adeline, et al.
Publicado: (2014)